Ontology highlight
ABSTRACT: The involvement of membrane-bound solute carriers (SLCs) in neoplastic transdifferentiation processes is poorly defined. Here, we examined changes in the SLC landscape during epithelial-mesenchymal transition (EMT) of pancreatic cancer cells. We show that two SLCs from the organic anion/cation transporter family, SLC22A10 and SLC22A15, favor EMT via interferon (IFN) α and γ signaling activation of receptor tyrosine kinase-like orphan receptor 1 (ROR1) expression. In addition, SLC22A10 and SLC22A15 allow tumor cell accumulation of glutathione to support EMT via the IFNα/γ-ROR1 axis. Moreover, a pan-SLC22A inhibitor lesinurad reduces EMT-induced metastasis and gemcitabine chemoresistance to prolong survival in mouse models of pancreatic cancer, thus identifying new vulnerabilities for human PDAC.
INSTRUMENT(S): Liquid Chromatography MS - positive - reverse phase
SUBMITTER: Debasis Nayak
PROVIDER: MTBLS1925 | MetaboLights | 2021-10-15
REPOSITORIES: MetaboLights
Action | DRS | |||
---|---|---|---|---|
MTBLS1925 | Other | |||
FILES | Other | |||
a_MTBLS1925_LC-MS_positive_reverse-phase_metabolite_profiling-1.txt | Txt | |||
files-all.json | Other | |||
i_Investigation.txt | Txt |
Items per page: 5 1 - 5 of 7 |